These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 25461404)

  • 1. ADAM17 regulates IL-1 signaling by selectively releasing IL-1 receptor type 2 from the cell surface.
    Uchikawa S; Yoda M; Tohmonda T; Kanaji A; Matsumoto M; Toyama Y; Horiuchi K
    Cytokine; 2015 Feb; 71(2):238-45. PubMed ID: 25461404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of Interleukin-1 and Interleukin-1 Receptors Type 1 and Type 2 in Hodgkin Lymphoma.
    Oelmann E; Stein H; Berdel WE; Herbst H
    PLoS One; 2015; 10(9):e0138747. PubMed ID: 26406983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulated intramembrane proteolysis of the interleukin-1 receptor II by alpha-, beta-, and gamma-secretase.
    Kuhn PH; Marjaux E; Imhof A; De Strooper B; Haass C; Lichtenthaler SF
    J Biol Chem; 2007 Apr; 282(16):11982-95. PubMed ID: 17307738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of IL-1 signaling by the decoy receptor IL-1R2.
    Schlüter T; Schelmbauer C; Karram K; Mufazalov IA
    J Mol Med (Berl); 2018 Oct; 96(10):983-992. PubMed ID: 30109367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different ADAMs have distinct influences on Kit ligand processing: phorbol-ester-stimulated ectodomain shedding of Kitl1 by ADAM17 is reduced by ADAM19.
    Kawaguchi N; Horiuchi K; Becherer JD; Toyama Y; Besmer P; Blobel CP
    J Cell Sci; 2007 Mar; 120(Pt 6):943-52. PubMed ID: 17344430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The interleukin-6 receptor Asp358Ala single nucleotide polymorphism rs2228145 confers increased proteolytic conversion rates by ADAM proteases.
    Garbers C; Monhasery N; Aparicio-Siegmund S; Lokau J; Baran P; Nowell MA; Jones SA; Rose-John S; Scheller J
    Biochim Biophys Acta; 2014 Sep; 1842(9):1485-94. PubMed ID: 24878322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Minimal interleukin 6 (IL-6) receptor stalk composition for IL-6 receptor shedding and IL-6 classic signaling.
    Baran P; Nitz R; Grötzinger J; Scheller J; Garbers C
    J Biol Chem; 2013 May; 288(21):14756-68. PubMed ID: 23564454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The membrane-proximal domain of A Disintegrin and Metalloprotease 17 (ADAM17) is responsible for recognition of the interleukin-6 receptor and interleukin-1 receptor II.
    Lorenzen I; Lokau J; Düsterhöft S; Trad A; Garbers C; Scheller J; Rose-John S; Grötzinger J
    FEBS Lett; 2012 Apr; 586(8):1093-100. PubMed ID: 22575642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A transforming Src mutant increases the bioavailability of EGFR ligands via stimulation of the cell-surface metalloproteinase ADAM17.
    Maretzky T; Zhou W; Huang XY; Blobel CP
    Oncogene; 2011 Feb; 30(5):611-8. PubMed ID: 20871631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin (IL)-1 in rat parturition: IL-1 receptors 1 and 2 and accessory proteins abundance in pregnant rat uterus at term - regulation by progesterone.
    Ishiguro T; Takeda J; Fang X; Bronson H; Olson DM
    Physiol Rep; 2016 Jul; 4(14):. PubMed ID: 27440742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-1 receptor type 2 suppresses collagen-induced arthritis by inhibiting IL-1 signal on macrophages.
    Shimizu K; Nakajima A; Sudo K; Liu Y; Mizoroki A; Ikarashi T; Horai R; Kakuta S; Watanabe T; Iwakura Y
    J Immunol; 2015 Apr; 194(7):3156-68. PubMed ID: 25725107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Type II interleukin-1 receptor expression is reduced in monocytes/macrophages and atherosclerotic lesions.
    Pou J; Martínez-González J; Rebollo A; Rodríguez C; Rodríguez-Calvo R; Martín-Fuentes P; Cenarro A; Civeira F; Laguna JC; Alegret M
    Biochim Biophys Acta; 2011 Sep; 1811(9):556-63. PubMed ID: 21683158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mouse neutrophils express the decoy type 2 interleukin-1 receptor (IL-1R2) constitutively and in acute inflammatory conditions.
    Martin P; Palmer G; Vigne S; Lamacchia C; Rodriguez E; Talabot-Ayer D; Rose-John S; Chalaris A; Gabay C
    J Leukoc Biol; 2013 Oct; 94(4):791-802. PubMed ID: 23817563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-1 induces proinflammatory leukocyte infiltration and regulates fibroblast phenotype in the infarcted myocardium.
    Saxena A; Chen W; Su Y; Rai V; Uche OU; Li N; Frangogiannis NG
    J Immunol; 2013 Nov; 191(9):4838-48. PubMed ID: 24078695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural basis for inflammation-driven shedding of CD163 ectodomain and tumor necrosis factor-α in macrophages.
    Etzerodt A; Rasmussen MR; Svendsen P; Chalaris A; Schwarz J; Galea I; Møller HJ; Moestrup SK
    J Biol Chem; 2014 Jan; 289(2):778-88. PubMed ID: 24275664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular and functional characterization of IL-1 receptor type 2 in grass carp: a potent inhibitor of IL-1β signaling in head kidney leukocytes.
    Yang X; Wang S; Du L; Yang K; Wang X; Zhang A; Zhou H
    Dev Comp Immunol; 2013 Dec; 41(4):738-45. PubMed ID: 23999049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Shedding of interleukin-6 receptor and tumor necrosis factor alpha. Contribution of the stalk sequence to the cleavage pattern of transmembrane proteins.
    Althoff K; Reddy P; Voltz N; Rose-John S; Müllberg J
    Eur J Biochem; 2000 May; 267(9):2624-31. PubMed ID: 10785383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chorionic gonadotropin down-regulates the expression of the decoy inhibitory interleukin 1 receptor type II in human endometrial epithelial cells.
    Herrmann-Lavoie C; Rao CV; Akoum A
    Endocrinology; 2007 Nov; 148(11):5377-84. PubMed ID: 17702847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-1 receptor 2 (IL-1R2) and its role in immune regulation.
    Peters VA; Joesting JJ; Freund GG
    Brain Behav Immun; 2013 Aug; 32():1-8. PubMed ID: 23195532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Keratinocyte expression of the type 2 interleukin 1 receptor mediates local and specific inhibition of interleukin 1-mediated inflammation.
    Rauschmayr T; Groves RW; Kupper TS
    Proc Natl Acad Sci U S A; 1997 May; 94(11):5814-9. PubMed ID: 9159157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.